CD55 抗体
Quick Overview for CD55 抗体 (ABIN2480958)
抗原
See all CD55 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
产品特性
- Purified IgG
-
纯化方法
- Purified
-
免疫原
- K562 cells
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.0 mg/mL
-
-
-
Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor." in: The Journal of biological chemistry, Vol. 283, Issue 35, pp. 23922-30, (2008) (PubMed).
: "A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis." in: Annals of the rheumatic diseases, Vol. 64, Issue 1, pp. 64-9, (2004) (PubMed).
: "
-
Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor." in: The Journal of biological chemistry, Vol. 283, Issue 35, pp. 23922-30, (2008) (PubMed).
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
别名
- CD55
-
背景
- Synonyms: DAF
-
基因ID
- 1604
-
UniProt
- P08174
-
途径
- Complement System, Regulation of Leukocyte Mediated Immunity
抗原
-